Nitric oxide compounds have different effects profiles on human articular chondrocyte metabolism

Arthritis Research & Therapy

Francisco J Blanco¹  Joaquín Arenas²  Miguel A Martín²  Emilia Maneiro³  María C de Andrés³ 

[1]RETIC-RIER-ISCIII, Madrid, Spain

[2]Instituto de Investigación Hospital 12 de Octubre, "i+12", Madrid, Spain

[3]INIBIC-Complejo Hospitalario Universitario A Coruña (CHUAC) Rheumatology Division, As Xubias 84, 15006-A Coruña, Spain

关键词: osteoarthritis;    glucose;    mitochondria;    apoptosis;    nitric oxide;    chondrocytes;   

Others  :  795456
DOI  :  10.1186/ar4295

 received in 2013-01-19, accepted in 2013-09-11,  发布年份 2013

【 摘 要 】

Introduction

The pathogenesis of osteoarthritis (OA) is characterized by the production of high amounts of nitric oxide (NO), as a consequence of up-regulation of chondrocyte-inducible nitric oxide synthase (iNOS) induced by inflammatory cytokines. NO donors represent a powerful tool for studying the role of NO in the cartilage in vitro. There is no consensus about NO effects on articular cartilage in part because the differences between the NO donors available. The aim of this work is to compare the metabolic profile of traditional and new generation NO donors to see which one points out the osteoarthritic process in the best way.

Methods

Human healthy and OA chondrocytes were isolated from patients undergoing joint replacement surgery, and primary cultured. Cells were stimulated with NO donors (NOC-12 or SNP). NO production was evaluated by the Griess method, and apoptosis was quantified by flow cytometry. Mitochondrial function was evaluated by analysing respiratory chain enzyme complexes, citrate synthase (CS) activities by enzymatic assay, mitochondrial membrane potential (Δψm) by JC-1 using flow cytometry, and ATP levels were measured by luminescence assays. Glucose transport was measured as the uptake of 2-deoxy-[³H]glucose (2-[³H]DG). Statistical analysis was performed using the Mann-Whitney U test.

Results

NOC-12 liberates approximately ten times more NO₂^- than SNP, but the level of cell death induced was not as profound as that produced by SNP. Normal articular chondrocytes stimulated with NOC-12 had reduced activity from complexes I, III y IV, and the mitochondrial mass was increased in these cells. Deleterious effects on ΔΨm and ATP levels were more profound with SNP, and this NO donor was able to reduce 2-[³H]DG levels. Both NO donors had opposite effects on lactate release, SNP diminished the levels and NOC-12 lead to lactate accumulation. OA chondrocytes incorporate significantly more 2-[³H]DG than healthy cells.

Conclusions

These findings suggest that the new generation donors, specifically NOC-12, mimic the OA metabolic process much better than SNP. Previous results using SNP have to be considered prudently since most of the effects observed can be induced by the interactions of secondary products of NO.

【 授权许可】

   
2013 de Andrés et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

【 参考文献 】

• [1]Sandell LJ, Aigner T: Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis. Arthritis Res 2001, 3:107-113. BioMed Central Full Text
• [2]Nahir AM, Vitis N, Silbermann M: Cellular enzymatic activities in the articular cartilage of osteoarthritic and osteoporotic hip joints of humans: a quantitative cytochemical study. Aging (Milano) 1990, 2:363-369.
• [3]Dunham J, Hoedt-Schmidt S, Kalbhen DA: Structural and metabolic changes in articular cartilage induced by iodoacetate. Int J Exp Pathol 1992, 73:455-464.
• [4]Stadler J, Stefanovic-Racic M, Billiar TR, Curran RD, McIntyre LA, Georgescu HI, Simmons RL, Evans CH: Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol 1991, 147:3915-3920.
• [5]Hashimoto S, Takahashi K, Amiel D, Coutts RD, Lotz M: Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis. Arthritis Rheum 1998, 41:1266-1274.
• [6]Pelletier JP, Lascau-Coman V, Jovanovic D, Fernandes JC, Manning P, Connor JR, Currie MG, Martel-Pelletier J: Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors. J Rheumatol 1999, 26:2002-2014.
• [7]Studer RK, Georgescu HI, Miller LA, Evans CH: Inhibition of transforming growth factor beta production by nitric oxide-treated chondrocytes: implications for matrix synthesis. Arthritis Rheum 1999, 42:248-257.
• [8]Blanco FJ, Ochs RL, Schwarz H, Lotz M: Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 1995, 146:75-85.
• [9]Notoya K, Jovanovic DV, Reboul P, Martel-Pelletier J, Mineau F, Pelletier JP: The induction of cell death in human osteoarthritis chondrocytes by nitric oxide is related to the production of prostaglandin E2 via the induction of cyclooxygenase-2. J Immunol 2000, 165:3402-3410.
• [10]Maneiro E, Lopez-Armada MJ, de Andres MC, Carames B, Martin MA, Bonilla A, Del Hoyo P, Galdo F, Arenas J, Blanco FJ: Effect of nitric oxide on mitochondrial respiratory activity of human articular chondrocytes. Ann Rheum Dis 2005, 64:388-395.
• [11]Studer RK, Levicoff E, Georgescu H, Miller L, Jaffurs D, Evans CH: Nitric oxide inhibits chondrocyte response to IGF-I: inhibition of IGF-IRbeta tyrosine phosphorylation. Am J Physiol Cell Physiol 2000, 279:C961-969.
• [12]Johnson K, Jung A, Murphy A, Andreyev A, Dykens J, Terkeltaub R: Mitochondrial oxidative phosphorylation is a downstream regulator of nitric oxide effects on chondrocyte matrix synthesis and mineralization. Arthritis Rheum 2000, 43:1560-1570.
• [13]Tomita M, Sato EF, Nishikawa M, Yamano Y, Inoue M: Nitric oxide regulates mitochondrial respiration and functions of articular chondrocytes. Arthritis Rheum 2001, 44:96-104.
• [14]Brookes PS, Bolanos JP, Heales SJ: The assumption that nitric oxide inhibits mitochondrial ATP synthesis is correct. FEBS Lett 1999, 446:261-263.
• [15]Brown GC: Nitric oxide and mitochondrial respiration. Biochim Biophys Acta 1999, 1411:351-369.
• [16]Koivisto A, Pittner J, Froelich M, Persson AE: Oxygen-dependent inhibition of respiration in isolated renal tubules by nitric oxide. Kidney Int 1999, 55:2368-2375.
• [17]Richardson S, Neama G, Phillips T, Bell S, Carter SD, Moley KH, Moley JF, Vannucci SJ, Mobasheri A: Molecular characterization and partial cDNA cloning of facilitative glucose transporters expressed in human articular chondrocytes; stimulation of 2-deoxyglucose uptake by IGF-I and elevated MMP-2 secretion by glucose deprivation. Osteoarthritis Cartilage 2003, 11:92-101.
• [18]Gonsalves M, Barker AL, Macpherson JV, Unwin PR, O'Hare D, Winlove CP: Scanning electrochemical microscopy as a local probe of oxygen permeability in cartilage. Biophys J 2000, 78:1578-1588.
• [19]Oegema TRJ, Thompson RC: Metabolism of chondrocytes derived from normal and osteoarthritic human cartilage. In Articular cartilage biochemistry. Edited by Kuettner K. New York: Raven Press; 1986:257-271.
• [20]Murphy AN, Fiskum G, Beal MF: Mitochondria in neurodegeneration: bioenergetic function in cell life and death. J Cereb Blood Flow Metab 1999, 19:231-245.
• [21]Lee RB, Urban JP: Evidence for a negative Pasteur effect in articular cartilage. Biochem J 1997, 321(Pt 1):95-102.
• [22]Petit PX, Lecoeur H, Zorn E, Dauguet C, Mignotte B, Gougeon ML: Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J Cell Biol 1995, 130:157-167.
• [23]Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssiere JL, Petit PX, Kroemer G: Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med 1995, 181:1661-1672.
• [24]Kroemer G, Zamzami N, Susin SA: Mitochondrial control of apoptosis. Immunol Today 1997, 18:44-51.
• [25]Green DR, Reed JC: Mitochondria and apoptosis. Science 1998, 281:1309-1312.
• [26]Loeffler M, Kroemer G: The mitochondrion in cell death control: certainties and incognita. Exp Cell Res 2000, 256:19-26.
• [27]Mobasheri A, Neama G, Bell S, Richardson S, Carter SD: Human articular chondrocytes express three facilitative glucose transporter isoforms: GLUT1, GLUT3 and GLUT9. Cell Biol Int 2002, 26:297-300.
• [28]Rajpurohit R, Risbud MV, Ducheyne P, Vresilovic EJ, Shapiro IM: Phenotypic characteristics of the nucleus pulposus: expression of hypoxia inducing factor-1, glucose transporter-1 and MMP-2. Cell Tissue Res 2002, 308:401-407.
• [29]Pfander D, Cramer T, Schipani E, Johnson RS: HIF-1alpha controls extracellular matrix synthesis by epiphyseal chondrocytes. J Cell Sci 2003, 116:1819-1826.
• [30]Lee HC, Yin PH, Lu CY, Chi CW, Wei YH: Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells. Biochem J 2000, 348(Pt 2):425-432.
• [31]Del Carlo M Jr, Loeser RF: Nitric oxide-mediated chondrocyte cell death requires the generation of additional reactive oxygen species. Arthritis Rheum 2002, 46:394-403.
• [32]Hou YC, Janczuk A, Wang PG: Current trends in the development of nitric oxide donors. Curr Pharm Des 1999, 5:417-441.
• [33]Hrabie JA, Klose JR, Wink DA, Keefer LK: New nitric oxide-releasing zwitterions derived from polyamines. J Org Chem 1993, 58:1472-1476.
• [34]Fitzhugh AL, Keefer LK: Diazeniumdiolates: pro- and antioxidant applications of the "NONOates". Free Radic Biol Med 2000, 28:1463-1469.
• [35]Maneiro E, Martin MA, de Andres MC, Lopez-Armada MJ, Fernandez-Sueiro JL, del Hoyo P, Galdo F, Arenas J, Blanco FJ: Mitochondrial respiratory activity is altered in osteoarthritic human articular chondrocytes. Arthritis Rheum 2003, 48:700-708.
• [36]Maneiro E, de Andres MC, Fernandez-Sueiro JL, Galdo F, Blanco FJ: The biological action of hyaluronan on human osteoartritic articular chondrocytes: the importance of molecular weight. Clin Exp Rheumatol 2004, 22:307-312.
• [37]Takuma K, Phuagphong P, Lee E, Enomoto R, Mori K, Baba A, Matsuda T: The nitric oxide donor NOC12 protects cultured astrocytes against apoptosis via a cGMP-dependent mechanism. Jpn J Pharmacol 2002, 89:64-71.
• [38]Thippeswamy T, McKay JS, Quinn JP, Morris R: Nitric oxide, a biological double-faced janus--is this good or bad? Histol Histopathol 2006, 21:445-458.
• [39]Carlo MD Jr, Loeser RF: Increased oxidative stress with aging reduces chondrocyte survival: correlation with intracellular glutathione levels. Arthritis Rheum 2003, 48:3419-3430.
• [40]Kim HA, Blanco FJ: Cell death and apoptosis in osteoarthritic cartilage. Curr Drug Targets 2007, 8:333-345.
• [41]Brune B, von Knethen A, Sandau KB: Nitric oxide (NO): an effector of apoptosis. Cell Death Differ 1999, 6:969-975.
• [42]Dimmeler S, Zeiher AM: Nitric oxide-an endothelial cell survival factor. Cell Death Differ 1999, 6:964-968.
• [43]Liu L, Stamler JS: NO: an inhibitor of cell death. Cell Death Differ 1999, 6:937-942.
• [44]Chung HT, Pae HO, Choi BM, Billiar TR, Kim YM: Nitric oxide as a bioregulator of apoptosis. Biochem Biophys Res Commun 2001, 282:1075-1079.
• [45]Boyd CS, Cadenas E: Nitric oxide and cell signaling pathways in mitochondrial-dependent apoptosis. Biol Chem 2002, 383:411-423.
• [46]Kim HA, Lee KB, Bae SC: The mechanism of low-concentration sodium nitroprusside-mediated protection of chondrocyte death. Arthritis Res Ther 2005, 7:R526-535. BioMed Central Full Text
• [47]Lotz MK, Carames B: Autophagy and cartilage homeostasis mechanisms in joint health, aging and OA. Nat Rev Rheumatol 2011, 7:579-587.
• [48]Bates JN, Baker MT, Guerra R Jr, Harrison DG: Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochem Pharmacol 1991, 42(Suppl):S157-165.
• [49]Moncada S, Erusalimsky JD: Does nitric oxide modulate mitochondrial energy generation and apoptosis? Nat Rev Mol Cell Biol 2002, 3:214-220.
• [50]Cillero-Pastor B, Carames B, Lires-Dean M, Vaamonde-Garcia C, Blanco FJ, Lopez-Armada MJ: Mitochondrial dysfunction activates cyclooxygenase 2 expression in cultured normal human chondrocytes. Arthritis Rheum 2008, 58:2409-2419.
• [51]Rego I, Fernandez-Moreno M, Fernandez-Lopez C, Gomez-Reino JJ, Gonzalez A, Arenas J, Blanco FJ: Role of European mitochondrial DNA haplogroups in the prevalence of hip osteoarthritis in Galicia, Northern Spain. Ann Rheum Dis 2010, 69:210-213.
• [52]Cillero-Pastor B, Martin MA, Arenas J, Lopez-Armada MJ, Blanco FJ: Effect of nitric oxide on mitochondrial activity of human synovial cells. BMC Musculoskelet Disord 2011, 12:42. BioMed Central Full Text
• [53]Nisoli E, Clementi E, Paolucci C, Cozzi V, Tonello C, Sciorati C, Bracale R, Valerio A, Francolini M, Moncada S, Carruba MO: Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 2003, 299:896-899.
• [54]Mobasheri A, Platt N, Thorpe C, Shakibaei M: Regulation of 2-deoxy-D-glucose transport, lactate metabolism, and MMP-2 secretion by the hypoxia mimetic cobalt chloride in articular chondrocytes. Ann NY Acad Sci 2006, 1091:83-93.
• [55]Otte P: Basic cell metabolism of articular cartilage. Manometric studies. Z Rheumatol 1991, 50:304-312.
• [56]Spencer CA, Palmer TN, Mason RM: Intermediary metabolism in the Swarm rat chondrosarcoma chondrocyte. Biochem J 1990, 265:911-914.
• [57]Le Goffe C, Vallette G, Jarry A, Bou-Hanna C, Laboisse CL: The in vitro manipulation of carbohydrate metabolism: a new strategy for deciphering the cellular defence mechanisms against nitric oxide attack. Biochem J 1999, 344(Pt 3):643-648.
• [58]Aulwurm UR, Brand KA: Increased formation of reactive oxygen species due to glucose depletion in primary cultures of rat thymocytes inhibits proliferation. Eur J Biochem 2000, 267:5693-5698.
• [59]Yun H, Lee M, Kim SS, Ha J: Glucose deprivation increases mRNA stability of vascular endothelial growth factor through activation of AMP-activated protein kinase in DU145 prostate carcinoma. J Biol Chem 2005, 280:9963-9972.
• [60]Natsuizaka M, Ozasa M, Darmanin S, Miyamoto M, Kondo S, Kamada S, Shindoh M, Higashino F, Suhara W, Koide H, Aita K, Nakagawa K, Kondo T, Asaka M, Okada F, Kobayashi M: Synergistic up-regulation of Hexokinase-2, glucose transporters and angiogenic factors in pancreatic cancer cells by glucose deprivation and hypoxia. Exp Cell Res 2007, 313:3337-3348.
• [61]Goldring MB: Update on the biology of the chondrocyte and new approaches to treating cartilage diseases. Best Pract Res Clin Rheumatol 2006, 20:1003-1025.
• [62]Henrotin YE, Bruckner P, Pujol JP: The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage 2003, 11:747-755.
• [63]Rosa SC, Goncalves J, Judas F, Mobasheri A, Lopes C, Mendes AF: Impaired glucose transporter-1 degradation and increased glucose transport and oxidative stress in response to high glucose in chondrocytes from osteoarthritic versus normal human cartilage. Arthritis Res Ther 2009, 11:R80. BioMed Central Full Text